GarvThakur.com

STOCK BROKER REVIEW | INVESTING | UPCOMING IPO | ALGO TRADING | TECHNICAL ANALYSIS
Login / Sign Up

Accretion Pharmaceuticals Limited IPO Subscriptions Status Live Today

 

Get Real-Time Updates on stock market trends and news

Get updates on stock market, Stock related news, Algo Trading, learn profitable strategies.

Join WhatsApp Channel

Accretion Pharmaceuticals Limited IPO

May 14, 2025 - May 16, 2025 Closed
Apply This IPO
Best Margin
Zero Brokerage
24*7 Customer Support.
Fastest mobile support
Upstox Pre-Apply with Upstox

Accretion Pharmaceuticals Limited IPO Details

Issue Open

14 May 2025

Issue Close

16 May 2025

IPO Price

₹96 to ₹101 per equity share

Face Value

₹10 per equity share

IPO Size

₹29.75 Cr.

Listing At

NSE, SME

IPO Lot Size

1,200 shares

 

IPO Investor Categories

• Qualified Institutional Buyers (QIB)- Qualified institutional buyers (QIBs) are large investors, their investment expertise, such as mutual funds, insurance companies, pension funds, and hedge funds, who are considered to have the expertise and resources to evaluate the investment opportunities as participate in IPOs of QIBs -Need to meet financial criteria and allow retail investors to bid shares at prices below the offer price.

• Non-Institutional Investors (NII) - Non-institutional investors (NIIs), on the other hand, generally consist of individual investors, high net worth individuals (HNIs), or companies that do not meet the financial criteria to be classified as QIBs and allowed to participate in IPOs at the same price as retail investors.

NII category has two subcategories:

1. sNII -"sNII" means "small non-institutional investor". This sub-category includes investors who have created shares worth ₹2 lakh and ₹10 lakh in IPO.

2. bNII - "bNII" means "large non-institutional investor". This sub-category includes the investors who have the created shares worth more than Rs. 10 lakh in IPO.

• Retail Individual Investors (RII) - Retail Individual Investors (RIIs) are individual investors who apply for shares worth up to ₹2 lakh in IPOs, aimed at encouraging retail participation in IPOs.

• Employee (EMP)- The employee (EMP) category in an IPO is reserved for employees, directors, and associates the employees of the issuing company. The issuing company and the IPO's chief executive officer determine the allocation of shares in this category.

• Others- An eligible group of shareholders or other investors with a reserved number of IPOs,

 

Frequently Asked Question

Post-issue shareholding of the Accretion Pharmaceuticals Limited IPO promoter is 73.48%.
Opening date of Accretion Pharmaceuticals Limited IPO is May 14, 2025.
Accretion Pharmaceuticals Limited IPO Share price Shares will be listed at NSE SME.
You will receive on Accretion Pharmaceuticals Limited IPO shares in your Demat account on May 19, 2025, if allotted.
Pre-issue shareholding of the accrete pharmaceuticals private limited promoter is 100.00%.
IPO application is an online process by using UPI or ASBA as a payment method. ASBA IPO application is already available in the net banking of your respective bank account and the UPI application is offered by your Stockbroker, you can invest in Kenrik Industries Limited using any neatest method at your convenience.
An IPO “Initial Public Offering” is the process by which a private company offers that’s shares to the public for the first time to raise capital.
The meaning of "Accretion Pharmaceuticals Limited IPO" is the Grey Market Premium (GMP) for the initial public offering (IPO) of Accretion Pharmaceuticals Limited IPO on the current day.
Minimum and maximum order quantity is 1 lot only.
Investors can check the status of their IPO application on the registrar's website by entering their application details or through their respective brokers.
Accretion Pharmaceuticals Limited IPO shares will get listed on May 21 2025.
The face value of Accretion Pharmaceuticals Limited IPO is ₹10 per share.
Key financial metrics, including revenue, profit margins, and other financial data, will be available in the company's prospectus and financial statements.
Lot size of the Accretion Pharmaceuticals Limited IPO is 1200 shares.
If you do not get the allotment of on Accretion Pharmaceuticals Limited IPO, your IPO application amount will be released or credited back to your bank account via which you applied for this IPO.
The price band for the Accretion Pharmaceuticals Limited IPO will be specified in the company's official prospectus.
Accretion Pharmaceuticals Limited IPO Products share price ₹96 to ₹101 per share.
Comments for Accretion Pharmaceuticals Limited IPO Subscriptions Status Live Today

0 comments